Home
NewsNewsBirths resulting from essential Infertility Treatments, including advanced procedures like artificial insemination and IVF, have seen a very positive and promising climb, accounting for almost 15.1% of the total births recorded in 2024.
Two years ago, in 2024, one in seven newborns was born via infertility treatments like artificial insemination or in vitro fertilization – IVF as per a study in Korea. The proportion with regard to multiple births, including twins, has also seen a growth.
Confirms Study on Analysis of Side Effects of Infertility Treatments and Preparation of Management Plans from Health Insurance Review & Assessment Service, 36,025 out of 238,235 total births in 2024, which is about 15.1%, took place due to infertility treatments.
While the overall number of births saw a dip of 21.1% in a matter of five years, from 302,348 that were recorded in 2019 to 238,235 in 2024, rise in births with infertility treatments in Korea saw a jump of 36.6%, from 26,371 to 36,025. Notably, the proportion of births via infertility treatments almost doubled, rising from 8.7% to 15.1% between 2019 and 2024.
It is worth noting that the increase when it comes to infertility treatments has also gone on to raise the multiple birth rate. The size of multiple births across all the newborns grew from 4.6% in 2019 to 5.7% in 2024.
The rise in births with infertility treatments in Korea is due to the increasing age of marriage as well as childbirth, in addition to the health insurance coverage expansion when it comes to infertility treatments.
The proportion of multiple births in infants that were born by way of infertility treatments saw a slight dip from 35.5% in 2019 to 27.3% in 2024. But this does remain significantly higher as compared to the 1.6–1.8% rate for multiple births due to natural pregnancies. Apparently, the likelihood of multiple pregnancies increases when many embryos are transferred at the time of infertility treatment in order to enhance the success rates. The major dip when it comes to multiple births is attributed to the rising awareness of risks like maternal complications and also cerebral palsy in infants, thereby leading more parents to choose single-embryo transfers.
A professor of obstetrics and gynecology at the Seoul National University Hospital and also president of the Korean Maternal-Fetal Medicine Society, Park Jung-shin, said, “When undergoing infertility treatments, the various high-risk factors associated with multiple pregnancies must be thoroughly considered.”
Luna and Kindbody are redefining Intelligence in Fertility Care through a strategic partnership that integrates wearable biomarker tracking into clinical pathways. By capturing real-time physiological data, the collaboration enables personalised insights, enhances decision-making, and creates a more connected, data-driven fertility journey for patients and care providers alike.
Sapyen and Avenues launch at-home fertility diagnostics, introducing a couple-first testing model in the UK. By integrating semen analysis and AMH testing into early care, this approach reduces clinic visits, accelerates diagnosis, and ensures balanced fertility evaluation, transforming how patients begin their reproductive health journey.
Nexpring Health has invested in May Health to accelerate the development of the Anavi™ System, a novel device designed to treat PCOS-Related Infertility. The technology aims to restore ovulation through a single office-based procedure, expanding treatment options for millions of women affected by polycystic ovary syndrome.
INVO Fertility would be introducing time-lapse incubation technology at its Wisconsin clinic, hence offering high-quality lab care, creative patient solutions, and advanced embryo monitoring for improved fertility results.
Costco, Sesame, and IVI RMA North America have announced strategic partnership to alter fertility care in the U.S. by removing biggest obstacles to care including high costs and limited access.
Carea has launched its Trying to Conceive - IVF/IUI mode to help women undergoing intricate fertility treatment with risks of inconsistent clinic continuity through continuous tracking and expert guidance.
The Minnesota bill for infertility treatments mandates comprehensive insurance coverage for diagnosis, IVF, and fertility preservation across public and private health plans. Set for implementation in 2027, the legislation expands access, modernises infertility definitions, and ensures cost-sharing protections to make reproductive healthcare more equitable.
